Physician profile
Eric J Berkowitz
NPI 1508008806
$16,136.05
in general payments reported to CMS, 2019-2025
18 companies · $2,440 in 2025
The $2,440 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,869 · 2020: $4,433 · 2021: $547 · 2022: $1,190 · 2023: $3,585 · 2024: $2,072 · 2025: $2,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,020 · Travel and Lodging: $2,327 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,019.77 |
| Travel and Lodging | $2,326.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,007.30 | 2019-2020 | |
| Abbott Laboratories | $3,179.66 | 2019-2025 | Aveir, Ensite, Amplatzer |
| Medtronic, INC. | $3,024.20 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Affera Mapping System |
| Boston Scientific Corporation | $2,260.37 | 2019-2024 | Watchman Access System |
| Biosense Webster, INC. | $904.75 | 2019-2025 | Carto 3, Na, Octaray Mapping Catheter |
| Cardiva Medical, INC. | $298.27 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.42 | 2019-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $256.44 | 2023 | Optimizer |
| Philips North America LLC | $211.84 | 2019-2022 | |
| Atricure, INC. | $152.91 | 2023 | |
| Sanofi-Aventis U.S. LLC | $149.67 | 2019-2024 | |
| Angiodynamics, INC. | $120.97 | 2023 | Angiovac |
| Janssen Pharmaceuticals, INC | $91.61 | 2019-2021 | |
| Acutus Medical, INC. | $64.02 | 2022 | |
| Pfizer INC. | $46.59 | 2019-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $44.43 | 2023-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $34.22 | 2019-2021 | |
| Lundbeck LLC | $20.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Berkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.